** Cancer therapy maker Legend Biotech's LEGN.O shares rise 5.6% to $35.96
** Co posts Q4 adj. net loss of 16 cents per share, compared to a loss of 24 cents per share a year earlier
** Cash and cash equivalents, and time deposits of $1.1 billion, as of December 31, 2024, which co believes will provide financial runway into Q2 2026
** LEGN has fallen 46.1% in the past 12 months
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。